NTLA · Intellia Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| John M. Leonard President and CEO | ▼ Sell | Open Market | 1,147,064 Shares held | 8/21/2026 | View profile |
| Fred E. Cohen Director | ▲ Buy | Grant | 216,653 Shares held | 6/9/2026 | View profile |
| James Basta EVP, General Counsel | ▼ Sell | Open Market | 156,794 Shares held | 3/2/2026 | View profile |
| Edward J. Dulac III Chief Financial Officer | ▼ Sell | Open Market | 148,175 Shares held | 7/22/2026 | View profile |
| William J. Chase Director | ▲ Buy | Grant | 143,893 Shares held | 6/9/2026 | View profile |
| Birgit C. Schultes EVP, Chief Scientific Officer | ▲ Buy | Grant | 137,733 Shares held | 3/1/2026 | View profile |
| David Lebwohl EVP, Chief Medical Officer | ▲ Buy | Grant | 131,192 Shares held | 3/1/2026 | View profile |
| Eliana Clark EVP, Chief Technical Officer | ▼ Sell | Open Market | 93,864 Shares held | 3/2/2026 | View profile |
| Sepp-Lorenzino Laura EVP, Chief Scientific Officer | ▼ Sell | Open Market | 77,388 Shares held | 1/3/2025 | View profile |
| Goddard Glenn EVP, Chief Financial Officer | ▲ Buy | Grant | 69,213 Shares held | 3/1/2024 | View profile |
| Michael P. Dube VP, Chief Accounting Officer | ▼ Sell | Open Market | 65,022 Shares held | 10/2/2026 | View profile |
| Hicks Derek EVP, Chief Business Officer | ▼ Sell | Open Market | 59,878 Shares held | 1/3/2025 | View profile |
| Georgia Keresty Director | ▲ Buy | Grant | 41,083 Shares held | 6/9/2026 | View profile |
| Muna Bhanji Director | ▲ Buy | Grant | 36,403 Shares held | 6/9/2026 | View profile |
| Frank Verwiel Director | ▲ Buy | Grant | 35,148 Shares held | 6/9/2026 | View profile |
| Jesse Goodman Director | ▲ Buy | Grant | 33,559 Shares held | 6/9/2026 | View profile |
| Brian Goff Chief Executive Officer | ▲ Buy | Grant | 32,609 Shares held | 6/9/2026 | View profile |
| Caroline Dorsa Director | ▲ Buy | Grant | 12,701 Shares held | 6/14/2022 | View profile |
| Crowley John F Director | ▲ Buy | Grant | 11,716 Shares held | 6/14/2023 | View profile |
| FORMELA JEAN FRANCOIS Director | ▲ Buy | Grant | 7,291 Shares held | 6/14/2022 | View profile |
Transaction History
| Michael P. Dube | ▼ Sell | Open Market | 1,864 | $23K | 10/2/2026 |
| John M. Leonard | ▼ Sell | Open Market | 2,785 | $36K | 8/21/2026 |
| John M. Leonard | ▼ Sell | Open Market | 19,890 | $251K | 8/20/2026 |
| Edward J. Dulac III | ▼ Sell | Open Market | 8,111 | $91K | 7/22/2026 |
| Edward J. Dulac III | ▼ Sell | Open Market | 4,677 | $84K | 7/2/2026 |
| Michael P. Dube | ▼ Sell | Open Market | 2,641 | $44K | 7/1/2026 |
| Frank Verwiel | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| Georgia Keresty | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| Jesse Goodman | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| Brian Goff | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| Fred E. Cohen | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| William J. Chase | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| Muna Bhanji | ▲ Buy | Grant | 9,200 | $0 | 6/9/2026 |
| James Basta | ▼ Sell | Open Market | 1,211 | $17K | 3/2/2026 |
| Eliana Clark | ▼ Sell | Open Market | 607 | $8K | 3/2/2026 |
| David Lebwohl | ▲ Buy | Grant | 9,943 | $0 | 3/1/2026 |
| John M. Leonard | ▲ Buy | Grant | 156,400 | $0 | 3/1/2026 |
| James Basta | ▲ Buy | Grant | 46,080 | $0 | 3/1/2026 |
| Edward J. Dulac III | ▲ Buy | Grant | 61,280 | $0 | 3/1/2026 |
| Birgit C. Schultes | ▲ Buy | Grant | 39,200 | $0 | 3/1/2026 |
| Michael P. Dube | ▲ Buy | Grant | 17,250 | $0 | 3/1/2026 |
| Eliana Clark | ▲ Buy | Grant | 7,353 | $0 | 3/1/2026 |
| Fred E. Cohen | ▲ Buy | Open Market | 150,000 | $1.4M | 1/5/2026 |
| David Lebwohl | ▼ Sell | Open Market | 11,903 | $110K | 1/5/2026 |
| Eliana Clark | ▼ Sell | Open Market | 9,515 | $88K | 1/5/2026 |
| Edward J. Dulac III | ▼ Sell | Open Market | 6,379 | $59K | 1/5/2026 |
| Michael P. Dube | ▼ Sell | Open Market | 2,989 | $28K | 1/5/2026 |
| John M. Leonard | ▼ Sell | Open Market | 34,146 | $314K | 1/5/2026 |
| Birgit C. Schultes | ▼ Sell | Open Market | 8,508 | $78K | 1/5/2026 |
| James Basta | ▼ Sell | Open Market | 10,397 | $96K | 1/5/2026 |
| John M. Leonard | ▲ Buy | Option Exercise | 8,557 | $58K | 12/12/2025 |
| John M. Leonard | ▲ Buy | Option Exercise | 49,959 | $341K | 12/11/2025 |
| John M. Leonard | ▼ Sell | Open Market | 49,959 | $474K | 12/11/2025 |
| John M. Leonard | ▼ Sell | Open Market | 32,832 | $311K | 12/11/2025 |
| John M. Leonard | ▼ Sell | Open Market | 5,355 | $51K | 12/11/2025 |
| Birgit C. Schultes | ▼ Sell | Open Market | 31 | $539 | 10/1/2025 |
| Michael P. Dube | ▼ Sell | Open Market | 1,871 | $33K | 10/1/2025 |
| William J. Chase | ▲ Buy | Open Market | 100,000 | $1.0M | 8/20/2025 |
| Edward J. Dulac III | ▼ Sell | Open Market | 7,462 | $105K | 7/23/2025 |
| Michael P. Dube | ▼ Sell | Open Market | 2,503 | $25K | 7/2/2025 |
| Eliana Clark | ▼ Sell | Open Market | 1,022 | $10K | 7/1/2025 |
| Jesse Goodman | ▼ Sell | Open Market | 1,547 | $14K | 7/1/2025 |
| Jesse Goodman | ▼ Sell | Open Market | 1,547 | $15K | 6/30/2025 |
| Georgia Keresty | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| Frank Verwiel | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| Jesse Goodman | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| Brian Goff | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| Muna Bhanji | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| William J. Chase | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| Fred E. Cohen | ▲ Buy | Grant | 8,000 | $0 | 6/11/2025 |
| Muna Bhanji | ▼ Sell | Open Market | 265 | $2K | 4/29/2025 |
| Eliana Clark | ▼ Sell | Open Market | 679 | $6K | 3/4/2025 |
| James Basta | ▼ Sell | Open Market | 2,572 | $23K | 3/4/2025 |
| David Lebwohl | ▲ Buy | Grant | 43,200 | $0 | 3/1/2025 |
| Michael P. Dube | ▲ Buy | Grant | 14,000 | $0 | 3/1/2025 |
| Edward J. Dulac III | ▲ Buy | Grant | 47,200 | $0 | 3/1/2025 |
| Eliana Clark | ▲ Buy | Grant | 32,000 | $0 | 3/1/2025 |
| Birgit C. Schultes | ▲ Buy | Grant | 37,600 | $0 | 3/1/2025 |
| John M. Leonard | ▲ Buy | Grant | 136,000 | $0 | 3/1/2025 |
| James Basta | ▲ Buy | Grant | 40,000 | $0 | 3/1/2025 |
| Muna Bhanji | ▼ Sell | Open Market | 265 | $3K | 1/29/2025 |
| Michael P. Dube | ▼ Sell | Open Market | 1,372 | $17K | 1/3/2025 |
| James Basta | ▼ Sell | Open Market | 7,074 | $86K | 1/3/2025 |
| David Lebwohl | ▼ Sell | Open Market | 9,557 | $116K | 1/3/2025 |
| Hicks Derek | ▼ Sell | Open Market | 6,502 | $79K | 1/3/2025 |
| John M. Leonard | ▼ Sell | Open Market | 26,807 | $327K | 1/3/2025 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 8,966 | $109K | 1/3/2025 |
| Eliana Clark | ▼ Sell | Open Market | 7,422 | $90K | 1/3/2025 |
| Eliana Clark | ▼ Sell | Open Market | 556 | $7K | 1/2/2025 |
| David Lebwohl | ▲ Buy | Option Exercise | 3,189 | — | 1/1/2025 |
| John M. Leonard | ▲ Buy | Option Exercise | 7,850 | — | 1/1/2025 |
| Sepp-Lorenzino Laura | ▲ Buy | Option Exercise | 3,500 | — | 1/1/2025 |
| Michael P. Dube | ▼ Sell | Open Market | 2,012 | $38K | 10/2/2024 |
| Edward J. Dulac III | ▲ Buy | Grant | 66,324 | $0 | 7/22/2024 |
| Eliana Clark | ▼ Sell | Open Market | 405 | $9K | 7/1/2024 |
| Michael P. Dube | ▲ Buy | Grant | 17,801 | $0 | 7/1/2024 |
| Frank Verwiel | ▼ Sell | Open Market | 1,505 | $38K | 6/17/2024 |
| Brian Goff | ▲ Buy | Grant | 15,409 | $0 | 6/13/2024 |
| Frank Verwiel | ▲ Buy | Grant | 7,737 | $0 | 6/12/2024 |
| Georgia Keresty | ▲ Buy | Grant | 7,737 | $0 | 6/12/2024 |
| Jesse Goodman | ▲ Buy | Grant | 7,737 | $0 | 6/12/2024 |
| Fred E. Cohen | ▲ Buy | Grant | 7,737 | $0 | 6/12/2024 |
| Muna Bhanji | ▲ Buy | Grant | 7,737 | $0 | 6/12/2024 |
| William J. Chase | ▲ Buy | Grant | 7,737 | $0 | 6/12/2024 |
| James Basta | ▼ Sell | Open Market | 2,297 | $76K | 3/4/2024 |
| Eliana Clark | ▼ Sell | Open Market | 605 | $20K | 3/4/2024 |
| Sepp-Lorenzino Laura | ▲ Buy | Grant | 37,966 | $0 | 3/1/2024 |
| James Basta | ▲ Buy | Grant | 32,394 | $0 | 3/1/2024 |
| Hicks Derek | ▲ Buy | Grant | 29,393 | $0 | 3/1/2024 |
| Eliana Clark | ▲ Buy | Grant | 31,230 | $0 | 3/1/2024 |
| John M. Leonard | ▲ Buy | Grant | 113,586 | $0 | 3/1/2024 |
| David Lebwohl | ▲ Buy | Grant | 38,701 | $0 | 3/1/2024 |
| Goddard Glenn | ▲ Buy | Grant | 28,628 | $0 | 3/1/2024 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 1,608 | $46K | 1/8/2024 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 667 | $20K | 1/8/2024 |
| John M. Leonard | ▼ Sell | Open Market | 19,223 | $566K | 1/3/2024 |
| David Lebwohl | ▼ Sell | Open Market | 5,843 | $172K | 1/3/2024 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 5,532 | $163K | 1/3/2024 |
| Goddard Glenn | ▼ Sell | Open Market | 5,365 | $158K | 1/3/2024 |
| Hicks Derek | ▼ Sell | Open Market | 3,877 | $114K | 1/3/2024 |
| James Basta | ▼ Sell | Open Market | 3,805 | $112K | 1/3/2024 |
| Eliana Clark | ▼ Sell | Open Market | 307 | $9K | 1/3/2024 |
| Eliana Clark | ▼ Sell | Open Market | 4,301 | $127K | 1/3/2024 |
| Sepp-Lorenzino Laura | ▲ Buy | Option Exercise | 3,500 | — | 1/1/2024 |
| David Lebwohl | ▲ Buy | Option Exercise | 3,187 | — | 1/1/2024 |
| John M. Leonard | ▲ Buy | Option Exercise | 7,848 | — | 1/1/2024 |
| Goddard Glenn | ▲ Buy | Option Exercise | 3,062 | — | 1/1/2024 |
| Muna Bhanji | ▼ Sell | Open Market | 265 | $6K | 10/31/2023 |
| Muna Bhanji | ▼ Sell | Open Market | 265 | $11K | 7/31/2023 |
| Muna Bhanji | ▼ Sell | Open Market | 1,867 | $73K | 7/6/2023 |
| Eliana Clark | ▼ Sell | Open Market | 360 | $15K | 7/3/2023 |
| Eliana Clark | ▲ Buy | Option Exercise | 5,000 | $61K | 6/20/2023 |
| Eliana Clark | ▼ Sell | Open Market | 5,000 | $225K | 6/20/2023 |
| Frank Verwiel | ▲ Buy | Grant | 4,425 | $0 | 6/14/2023 |
| Georgia Keresty | ▲ Buy | Grant | 4,425 | $0 | 6/14/2023 |
| Crowley John F | ▲ Buy | Grant | 4,425 | $0 | 6/14/2023 |
| Fred E. Cohen | ▲ Buy | Grant | 4,425 | $0 | 6/14/2023 |
| Muna Bhanji | ▲ Buy | Grant | 4,425 | $0 | 6/14/2023 |
| William J. Chase | ▲ Buy | Grant | 1,673 | $0 | 6/14/2023 |
| Jesse Goodman | ▲ Buy | Grant | 4,425 | $0 | 6/14/2023 |
| William J. Chase | ▲ Buy | Grant | 10,483 | $0 | 4/14/2023 |
| James Basta | ▼ Sell | Open Market | 1,088 | $48K | 3/2/2023 |
| James Basta | ▲ Buy | Grant | 24,539 | $0 | 3/1/2023 |
| Hicks Derek | ▲ Buy | Grant | 23,558 | $0 | 3/1/2023 |
| Goddard Glenn | ▲ Buy | Grant | 27,484 | $0 | 3/1/2023 |
| John M. Leonard | ▲ Buy | Grant | 91,036 | $0 | 3/1/2023 |
| Sepp-Lorenzino Laura | ▲ Buy | Grant | 29,938 | $0 | 3/1/2023 |
| Eliana Clark | ▲ Buy | Grant | 24,539 | $0 | 3/1/2023 |
| Eliana Clark | ▲ Buy | Grant | 6,134 | $0 | 3/1/2023 |
| James Basta | ▲ Buy | Grant | 12,269 | $0 | 3/1/2023 |
| David Lebwohl | ▲ Buy | Grant | 30,674 | $0 | 3/1/2023 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 1,641 | $63K | 1/5/2023 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 689 | $27K | 1/5/2023 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 2,508 | $93K | 1/4/2023 |
| John M. Leonard | ▼ Sell | Open Market | 6,673 | $248K | 1/4/2023 |
| Hicks Derek | ▼ Sell | Open Market | 1,812 | $67K | 1/4/2023 |
| David Lebwohl | ▼ Sell | Open Market | 2,574 | $96K | 1/4/2023 |
| Goddard Glenn | ▼ Sell | Open Market | 2,427 | $90K | 1/4/2023 |
| Eliana Clark | ▼ Sell | Open Market | 1,692 | $63K | 1/4/2023 |
| James Basta | ▼ Sell | Open Market | 1,138 | $42K | 1/4/2023 |
| Eliana Clark | ▼ Sell | Open Market | 231 | $8K | 1/3/2023 |
| Sepp-Lorenzino Laura | ▲ Buy | Option Exercise | 3,500 | — | 1/1/2023 |
| John M. Leonard | ▲ Buy | Option Exercise | 7,848 | — | 1/1/2023 |
| David Lebwohl | ▲ Buy | Option Exercise | 3,187 | — | 1/1/2023 |
| Goddard Glenn | ▲ Buy | Option Exercise | 3,062 | — | 1/1/2023 |
| Eliana Clark | ▼ Sell | Open Market | 105 | $5K | 7/1/2022 |
| Frank Verwiel | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| Georgia Keresty | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| Jesse Goodman | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| FORMELA JEAN FRANCOIS | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| Crowley John F | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| Fred E. Cohen | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| Muna Bhanji | ▲ Buy | Grant | 2,014 | $0 | 6/14/2022 |
| Caroline Dorsa | ▲ Buy | Grant | 5,197 | $0 | 6/14/2022 |
| Muna Bhanji | ▲ Buy | Grant | 7,954 | $0 | 4/28/2022 |
| Eliana Clark | ▲ Buy | Grant | 10,527 | $0 | 3/1/2022 |
| John M. Leonard | ▲ Buy | Grant | 40,990 | $0 | 3/1/2022 |
| Sepp-Lorenzino Laura | ▲ Buy | Grant | 13,816 | $0 | 3/1/2022 |
| David Lebwohl | ▲ Buy | Grant | 13,816 | $0 | 3/1/2022 |
| Goddard Glenn | ▲ Buy | Grant | 12,720 | $0 | 3/1/2022 |
| James Basta | ▲ Buy | Grant | 11,049 | $0 | 3/1/2022 |
| James Basta | ▲ Buy | Grant | 9,648 | $0 | 3/1/2022 |
| Hicks Derek | ▲ Buy | Grant | 19,118 | $0 | 1/3/2022 |
| Sepp-Lorenzino Laura | ▼ Sell | Open Market | 1,148 | $129K | 1/1/2022 |
| John M. Leonard | ▲ Buy | Option Exercise | 7,848 | — | 1/1/2022 |
| John M. Leonard | ▼ Sell | Open Market | 2,493 | $280K | 1/1/2022 |
| Sepp-Lorenzino Laura | ▲ Buy | Option Exercise | 3,500 | — | 1/1/2022 |
| David Lebwohl | ▲ Buy | Option Exercise | 3,187 | — | 1/1/2022 |
| David Lebwohl | ▼ Sell | Open Market | 1,051 | $118K | 1/1/2022 |
| Goddard Glenn | ▲ Buy | Option Exercise | 3,062 | — | 1/1/2022 |
| Goddard Glenn | ▼ Sell | Open Market | 1,013 | $114K | 1/1/2022 |
| David Lebwohl | ▲ Buy | Option Exercise | 2,400 | $30K | 11/5/2021 |
| David Lebwohl | ▼ Sell | Open Market | 1,200 | $158K | 11/5/2021 |
| David Lebwohl | ▼ Sell | Open Market | 452 | $60K | 11/5/2021 |
| David Lebwohl | ▼ Sell | Open Market | 548 | $73K | 11/5/2021 |
| David Lebwohl | ▼ Sell | Open Market | 200 | $27K | 11/5/2021 |
| David Lebwohl | ▼ Sell | Open Market | 849 | $109K | 10/14/2021 |
| David Lebwohl | ▲ Buy | Option Exercise | 2,400 | $30K | 10/14/2021 |
| David Lebwohl | ▼ Sell | Open Market | 551 | $70K | 10/14/2021 |
| David Lebwohl | ▼ Sell | Open Market | 225 | $29K | 10/14/2021 |
| David Lebwohl | ▼ Sell | Open Market | 525 | $68K | 10/14/2021 |
| David Lebwohl | ▼ Sell | Open Market | 250 | $33K | 10/14/2021 |
| Crowley John F | ▲ Buy | Option Exercise | 2,500 | $47K | 10/11/2021 |
| Crowley John F | ▼ Sell | Open Market | 2,500 | $299K | 10/11/2021 |
| Crowley John F | ▲ Buy | Option Exercise | 10,000 | $188K | 10/5/2021 |
| Crowley John F | ▼ Sell | Open Market | 1,280 | $165K | 10/5/2021 |
| Crowley John F | ▼ Sell | Open Market | 2,915 | $379K | 10/5/2021 |
| Crowley John F | ▼ Sell | Open Market | 3,759 | $492K | 10/5/2021 |
| Crowley John F | ▼ Sell | Open Market | 200 | $27K | 10/5/2021 |
| Crowley John F | ▼ Sell | Open Market | 1,846 | $243K | 10/5/2021 |
| David Lebwohl | ▲ Buy | Option Exercise | 7,923 | $100K | 9/24/2021 |
| David Lebwohl | ▲ Buy | Option Exercise | 2,400 | $30K | 9/21/2021 |
| David Lebwohl | ▼ Sell | Open Market | 2,400 | $360K | 9/21/2021 |
| Goddard Glenn | ▲ Buy | Option Exercise | 3,482 | $51K | 9/7/2021 |
| Goddard Glenn | ▼ Sell | Open Market | 3,482 | $627K | 9/7/2021 |
| John M. Leonard | ▲ Buy | Option Exercise | 28,750 | $674K | 9/1/2021 |
| John M. Leonard | ▲ Buy | Option Exercise | 15,985 | $293K | 9/1/2021 |
| John M. Leonard | ▼ Sell | Open Market | 44,735 | $7.6M | 9/1/2021 |
| John M. Leonard | ▲ Buy | Option Exercise | 37,833 | $552K | 8/31/2021 |
| John M. Leonard | ▼ Sell | Open Market | 37,833 | $5.9M | 8/31/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Intellia Therapeutics Appoints New Chief Medical Officer
Intellia Therapeutics announced the appointment of Jing L. Marantz as its new Chief Medical Officer. This leadership change occurred as the stock recently rose 7.6%, moving away from recent support levels. The news highlights a strategic shift in the company's medical leadership during a period of increased market activity.
Intellia Therapeutics Appoints New Chief Medical Officer. Intellia Therapeutics announced the appointment of Jing L. Marantz as its new Chief Medical Officer. This leadership change occurred as the stock recently rose 7.6%, moving away from recent support levels. The news highlights a strategic shift in the company's medical leadership during a period of increased market activity.